BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12686661)

  • 21. [Assessment of plasminogen activator inhibitor-1 and von Willebrand factor as a markers of endothelial function in patients with end-stage kidney disease after allotransplantation during a one-year follow-up].
    Doroszewski W; Włodarczyk Z; Strózecki P; Manitius J; Grabarczyk E; Rość D; Odrowaz-Sypniewska G
    Pol Arch Med Wewn; 2007; 117(5-6):213-20. PubMed ID: 18030870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
    Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J
    PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial.
    de Jager J; Kooy A; Schalkwijk C; van der Kolk J; Lehert P; Bets D; Wulffelé MG; Donker AJ; Stehouwer CD
    J Intern Med; 2014 Jan; 275(1):59-70. PubMed ID: 23981104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between homocysteine and endothelial dysfunction markers in stroke disease.
    Abdulle AM; Pathan JY; Moussa N; Gariballa S
    Nutr Neurosci; 2010 Feb; 13(1):2-6. PubMed ID: 20132648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis.
    Wiseman S; Marlborough F; Doubal F; Webb DJ; Wardlaw J
    Cerebrovasc Dis; 2014; 37(1):64-75. PubMed ID: 24401164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.
    Mezzano D; Pais EO; Aranda E; Panes O; Downey P; Ortiz M; Tagle R; González F; Quiroga T; Caceres MS; Leighton F; Pereira J
    Kidney Int; 2001 Nov; 60(5):1844-50. PubMed ID: 11703602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Markers of endothelial dysfunction in patients with iodine induced hyperthyroidism].
    Zonenberg A; Telejko B; Szelachowska M; Modzelewska A; Nikołajuk A; Górska M
    Endokrynol Pol; 2006; 57(3):210-7. PubMed ID: 16832784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.
    Jager A; van Hinsbergh VW; Kostense PJ; Emeis JJ; Nijpels G; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):593-8. PubMed ID: 11950696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients.
    Pawlak K; Myśliwiec M; Pawlak D
    Adv Med Sci; 2010; 55(2):196-203. PubMed ID: 20439183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
    Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
    Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function.
    Adams MJ; Irish AB; Watts GF; Oostryck R; Dogra GK
    Thromb Res; 2008; 123(2):374-80. PubMed ID: 18486198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markers of Oxidative Stress and Endothelial Dysfunction Predict Haemodialysis Patients Survival.
    Suvakov S; Jerotic D; Damjanovic T; Milic N; Pekmezovic T; Djukic T; Jelic-Ivanovic Z; Savic Radojevic A; Pljesa-Ercegovac M; Matic M; McClements L; Dimkovic N; Garovic VD; Albright RC; Simic T
    Am J Nephrol; 2019; 50(2):115-125. PubMed ID: 31238306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor.
    Preston RA; Ledford M; Materson BJ; Baltodano NM; Memon A; Alonso A
    J Hypertens; 2002 May; 20(5):871-7. PubMed ID: 12011647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers.
    Stewart FM; Freeman DJ; Ramsay JE; Greer IA; Caslake M; Ferrell WR
    J Clin Endocrinol Metab; 2007 Mar; 92(3):969-75. PubMed ID: 17192290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study.
    Thorand B; Baumert J; Döring A; Schneider A; Chambless L; Löwel H; Kolb H; Koenig W
    Thromb Haemost; 2006 Jan; 95(1):134-41. PubMed ID: 16543972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy.
    Guzmán-Fulgencio M; Medrano J; Rallón N; Echeverria-Urabayen A; Miguel Benito J; Restrepo C; García-Álvarez M; Vispo E; San Roman J; Sánchez-Piedra C; Soriano V; Resino S
    J Infect; 2011 Nov; 63(5):382-90. PubMed ID: 21855573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients.
    van Ree RM; Oterdoom LH; de Vries AP; Homan van der Heide JJ; van Son WJ; Navis G; Gans RO; Bakker SJ
    Transplantation; 2008 Dec; 86(12):1713-9. PubMed ID: 19104410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.